146 related articles for article (PubMed ID: 25249198)
1. TRAF4 mediates activation of TGF-β signaling and is a biomarker for oncogenesis in breast cancer.
Zhou F; Li F; Xie F; Zhang Z; Huang H; Zhang L
Sci China Life Sci; 2014 Dec; 57(12):1172-6. PubMed ID: 25249198
[TBL] [Abstract][Full Text] [Related]
2. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis.
Zhang L; Zhou F; García de Vinuesa A; de Kruijf EM; Mesker WE; Hui L; Drabsch Y; Li Y; Bauer A; Rousseau A; Sheppard KA; Mickanin C; Kuppen PJ; Lu CX; Ten Dijke P
Mol Cell; 2013 Sep; 51(5):559-72. PubMed ID: 23973329
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor-beta signaling that affects neural crest formation.
Kalkan T; Iwasaki Y; Park CY; Thomsen GH
Mol Biol Cell; 2009 Jul; 20(14):3436-50. PubMed ID: 19458200
[TBL] [Abstract][Full Text] [Related]
4. Noncanonical TGF-β signaling leads to FBXO3-mediated degradation of ΔNp63α promoting breast cancer metastasis and poor clinical prognosis.
Niu M; He Y; Xu J; Ding L; He T; Yi Y; Fu M; Guo R; Li F; Chen H; Chen YG; Xiao ZJ
PLoS Biol; 2021 Feb; 19(2):e3001113. PubMed ID: 33626035
[TBL] [Abstract][Full Text] [Related]
5. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
6. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic TRAF4 contributes to the activation of p70s6k signaling pathway in breast cancer.
Ren HY; Wang J; Yang F; Zhang XL; Wang AL; Sun LL; Diao KX; Wang EH; Mi XY
Oncotarget; 2015 Feb; 6(6):4080-96. PubMed ID: 25738361
[TBL] [Abstract][Full Text] [Related]
8. Mediator MED15 modulates transforming growth factor beta (TGFβ)/Smad signaling and breast cancer cell metastasis.
Zhao M; Yang X; Fu Y; Wang H; Ning Y; Yan J; Chen YG; Wang G
J Mol Cell Biol; 2013 Feb; 5(1):57-60. PubMed ID: 23014762
[No Abstract] [Full Text] [Related]
9. TRAF4, a new substrate of SIAH1, participates in chemotherapy resistance of breast cancer cell by counteracting SIAH1-mediated downregulation of β-catenin.
Ren H; Mi X; Zhao P; Zhao X; Wei N; Huang H; Meng Z; Kou J; Sun M; Liu Y; Zhang H; Yang J; Li W; Li H
Breast Cancer Res Treat; 2020 Sep; 183(2):275-289. PubMed ID: 32671611
[TBL] [Abstract][Full Text] [Related]
10. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
[TBL] [Abstract][Full Text] [Related]
12. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
Imamura T; Hikita A; Inoue Y
Breast Cancer; 2012 Apr; 19(2):118-24. PubMed ID: 22139728
[TBL] [Abstract][Full Text] [Related]
13. Expression, correlation, and prognostic value of TRAF2 and TRAF4 expression in malignant plural effusion cells in human breast cancer.
Zhao ZJ; Ren HY; Yang F; Wang J; Wu GP; Mi XY
Diagn Cytopathol; 2015 Nov; 43(11):897-903. PubMed ID: 26331901
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) by Smad ubiquitination regulatory factor 1 (Smurf1) regulates motility of breast epithelial and cancer cells.
Wang X; Jin C; Tang Y; Tang LY; Zhang YE
J Biol Chem; 2013 Jul; 288(30):21784-92. PubMed ID: 23760265
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Ubiquitin Enzymes in the TGF-β Pathway.
Iyengar PV
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28425962
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta signaling in cancer invasion and metastasis.
Leivonen SK; Kähäri VM
Int J Cancer; 2007 Nov; 121(10):2119-24. PubMed ID: 17849476
[TBL] [Abstract][Full Text] [Related]
17. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
18. Activation of the TGF-β/Smad signaling pathway in oncogenic transformation by v-Rel.
Tiwari R; Bargmann W; Bose HR
Virology; 2011 Apr; 413(1):60-71. PubMed ID: 21345476
[TBL] [Abstract][Full Text] [Related]
19. Coordination of TGF-β signaling by ubiquitylation.
Moustakas A; Heldin CH
Mol Cell; 2013 Sep; 51(5):555-6. PubMed ID: 24034692
[TBL] [Abstract][Full Text] [Related]
20. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.
Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ
Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
